Ralph J. Bernacki

4.9k total citations
128 papers, 4.0k citations indexed

About

Ralph J. Bernacki is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ralph J. Bernacki has authored 128 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 55 papers in Oncology and 43 papers in Organic Chemistry. Recurrent topics in Ralph J. Bernacki's work include Cancer Treatment and Pharmacology (35 papers), Glycosylation and Glycoproteins Research (33 papers) and Carbohydrate Chemistry and Synthesis (25 papers). Ralph J. Bernacki is often cited by papers focused on Cancer Treatment and Pharmacology (35 papers), Glycosylation and Glycoproteins Research (33 papers) and Carbohydrate Chemistry and Synthesis (25 papers). Ralph J. Bernacki collaborates with scholars based in United States, Italy and France. Ralph J. Bernacki's co-authors include Iwao Ojima, Paula Pera, Carl W. Porter, W. Korytnyk, Michael J. Niedbala, Jean Veith, Kent Crickard, Raymond J. Bergeron, H.Bruce Bosmann and Untae Kim and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Ralph J. Bernacki

125 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph J. Bernacki United States	38	2.4k	1.3k	1.1k	591	395	128	4.0k
Michael R. Mattern United States	46	5.8k 2.4×	2.6k 2.0×	758 0.7×	416 0.7×	295 0.7×	107	7.0k
Bridget T. Hill United Kingdom	39	3.0k 1.2×	2.2k 1.6×	555 0.5×	546 0.9×	157 0.4×	193	5.3k
Francis M. Sirotnak United States	42	2.8k 1.1×	1.9k 1.5×	622 0.6×	210 0.4×	198 0.5×	170	5.6k
Shigeru Tsukagoshi Japan	32	2.7k 1.1×	3.0k 2.2×	759 0.7×	134 0.2×	283 0.7×	144	5.4k
Claudio Pisano Italy	48	4.0k 1.6×	1.3k 0.9×	1.3k 1.2×	1.2k 2.1×	292 0.7×	169	6.0k
Laura Sepp‐Lorenzino United States	36	3.6k 1.5×	1.0k 0.8×	732 0.7×	517 0.9×	502 1.3×	78	4.9k
David W. Fry United States	45	4.0k 1.6×	3.6k 2.7×	2.2k 2.1×	764 1.3×	336 0.9×	122	8.4k
Rosanna Supino Italy	37	3.0k 1.2×	1.7k 1.3×	593 0.6×	196 0.3×	304 0.8×	109	4.9k
Peter Charlton United Kingdom	34	2.7k 1.1×	2.1k 1.6×	602 0.6×	313 0.5×	126 0.3×	74	4.5k
Christopher L. Morton United States	45	3.2k 1.3×	1.5k 1.1×	389 0.4×	344 0.6×	238 0.6×	128	5.6k

Countries citing papers authored by Ralph J. Bernacki

Since Specialization

Citations

This map shows the geographic impact of Ralph J. Bernacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph J. Bernacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph J. Bernacki more than expected).

Fields of papers citing papers by Ralph J. Bernacki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph J. Bernacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph J. Bernacki. The network helps show where Ralph J. Bernacki may publish in the future.

Co-authorship network of co-authors of Ralph J. Bernacki

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph J. Bernacki. A scholar is included among the top collaborators of Ralph J. Bernacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph J. Bernacki. Ralph J. Bernacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sajjad, M. Arif, Ufana Riaz, Rutao Yao, et al.. (2012). Investigation of 3′-debenzoyl-3′-(3-([124I]-iodobenzoyl))paclitaxel analog as a radio-tracer to study multidrug resistance in vivo. Applied Radiation and Isotopes. 70(8). 1624–1631. 2 indexed citations

Shah, Dhaval K., Beom Soo Shin, Jean Veith, et al.. (2009). Use of an Anti-Vascular Endothelial Growth Factor Antibody in a Pharmacokinetic Strategy to Increase the Efficacy of Intraperitoneal Chemotherapy. Journal of Pharmacology and Experimental Therapeutics. 329(2). 580–591. 33 indexed citations

Brooks, Tracy A., Kieran L. O’Loughlin, Hans Minderman, et al.. (2006). The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells. Investigational New Drugs. 25(2). 115–122. 12 indexed citations

Geney, Raphaël, Liang Sun, Paula Pera, et al.. (2005). Use of the Tubulin Bound Paclitaxel Conformation for Structure-Based Rational Drug Design. Chemistry & Biology. 12(3). 339–348. 64 indexed citations

De, Tapas, Jean Veith, Ralph J. Bernacki, Patrick Soon‐Shiong, & Neil Desai. (2005). Nab-028, a nanoparticle albumin-bound novel taxane, shows improved efficacy and lower toxicity over the tween formulation (Tween-028). Cancer Research. 65. 335–336. 4 indexed citations

Ling, Xiang, Ralph J. Bernacki, Michael G. Brattain, & Fengzhi Li. (2004). Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest. Journal of Biological Chemistry. 279(15). 15196–15203. 156 indexed citations

Minderman, Hans, Tracy A. Brooks, Kieran L. O’Loughlin, et al.. (2004). Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023. Cancer Chemotherapy and Pharmacology. 53(5). 363–369. 45 indexed citations

Ojima, Iwao, Jean Veith, Paula Pera, et al.. (2001). Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance. JNCI Journal of the National Cancer Institute. 93(16). 1234–1245. 74 indexed citations

Gruol, Donald J., et al.. (2001). The Use of a Novel Taxane-Based P-Glycoprotein Inhibitor to Identify Mutations That Alter the Interaction of the Protein with Paclitaxel. Molecular Pharmacology. 60(1). 104–113. 8 indexed citations

10.

Dimitroff, Charles J., Wayne D. Klohs, Amarnath Sharma, et al.. (1999). Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy. Investigational New Drugs. 17(2). 121–135. 71 indexed citations

11.

Ojima, Iwao, et al.. (1998). New taxanes as highly efficient reversal agents for multi-drug resistance in cancer cells. Bioorganic & Medicinal Chemistry Letters. 8(2). 189–194. 46 indexed citations

12.

Kramer, Debora L., Mirjana Fogel‐Petrovic, Paula Diegelman, et al.. (1997). Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells.. PubMed. 57(24). 5521–7. 47 indexed citations

13.

Bernacki, Ralph J., et al.. (1995). Versatile intermediates in the selective modification of the amino function of 2-amino-2-deoxy-d-mannopyranose and the 3-position of 2-acetamido-2-deoxy-d-mannose: Potential membrane modifiers in neoplastic control. Carbohydrate Research. 276(1). 99–115. 12 indexed citations

14.

Porter, Carl W., Ralph J. Bernacki, John Miller, & Raymond J. Bergeron. (1993). Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.. PubMed. 53(3). 581–6. 67 indexed citations

15.

Bernacki, Ralph J., Raymond J. Bergeron, & Carl W. Porter. (1992). Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.. PubMed. 52(9). 2424–30. 85 indexed citations

16.

Weiss, L., et al.. (1991). Effects of doxorubicin on the sensitivity of L1210 leukemia cells to deformation-associated trauma. Cell Biophysics. 18(1). 57–67. 1 indexed citations

17.

Bernacki, Ralph J., et al.. (1990). Antitumor properties of tetrahydrobenz(a)anthraquinone derivatives. Journal of Medicinal Chemistry. 33(2). 490–492. 5 indexed citations

18.

An, Sungwhan, et al.. (1989). 2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides. Journal of Medicinal Chemistry. 32(4). 799–807. 13 indexed citations

19.

Klohs, Wayne D., Khushi L. Matta, Joseph J. Barlow, & Ralph J. Bernacki. (1981). Phenyl 2-acetamido-2-deoxy-3-O-β-d-galactopyranosyl-α-d-galactopyranoside, a substrate for sialyltransferase. Carbohydrate Research. 89(2). 350–354. 4 indexed citations

20.

Bernacki, Ralph J., et al.. (1975). Studies on the role of n-acetylneuraminic acid (nana) on the uptake of spermidine in mouse leukemia l1210 cells. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact